![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TREM2 |
Gene summary for TREM2 |
![]() |
Gene information | Species | Human | Gene symbol | TREM2 | Gene ID | 54209 |
Gene name | triggering receptor expressed on myeloid cells 2 | |
Gene Alias | PLOSL2 | |
Cytomap | 6p21.1 | |
Gene Type | protein-coding | GO ID | GO:0000165 | UniProtAcc | Q9NZC2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
54209 | TREM2 | LZE6T | Human | Esophagus | ESCC | 9.93e-10 | 8.88e-01 | 0.0845 |
54209 | TREM2 | P16T-E | Human | Esophagus | ESCC | 6.19e-93 | 3.57e+00 | 0.1153 |
54209 | TREM2 | P17T-E | Human | Esophagus | ESCC | 4.70e-13 | 1.06e+00 | 0.1278 |
54209 | TREM2 | P22T-E | Human | Esophagus | ESCC | 7.95e-19 | 4.67e-01 | 0.1236 |
54209 | TREM2 | P56T-E | Human | Esophagus | ESCC | 8.17e-06 | 1.05e+00 | 0.1613 |
54209 | TREM2 | P65T-E | Human | Esophagus | ESCC | 3.48e-10 | 6.06e-01 | 0.0978 |
54209 | TREM2 | P74T-E | Human | Esophagus | ESCC | 1.66e-21 | 1.07e+00 | 0.1479 |
54209 | TREM2 | P76T-E | Human | Esophagus | ESCC | 1.99e-15 | 1.48e+00 | 0.1207 |
54209 | TREM2 | P83T-E | Human | Esophagus | ESCC | 3.65e-03 | 2.26e-01 | 0.1738 |
54209 | TREM2 | P107T-E | Human | Esophagus | ESCC | 4.07e-24 | 1.21e+00 | 0.171 |
54209 | TREM2 | C04 | Human | Oral cavity | OSCC | 1.62e-38 | 2.16e+00 | 0.2633 |
54209 | TREM2 | C21 | Human | Oral cavity | OSCC | 4.07e-23 | 7.57e-01 | 0.2678 |
54209 | TREM2 | C30 | Human | Oral cavity | OSCC | 8.42e-14 | 6.37e-01 | 0.3055 |
54209 | TREM2 | C06 | Human | Oral cavity | OSCC | 6.22e-04 | 7.50e-01 | 0.2699 |
54209 | TREM2 | C07 | Human | Oral cavity | OSCC | 8.27e-07 | 2.11e+00 | 0.2491 |
54209 | TREM2 | LN22 | Human | Oral cavity | OSCC | 3.59e-16 | 2.07e+00 | 0.1733 |
54209 | TREM2 | SYSMH2 | Human | Oral cavity | OSCC | 9.26e-07 | 2.78e-01 | 0.2326 |
54209 | TREM2 | SYSMH3 | Human | Oral cavity | OSCC | 1.63e-40 | 1.28e+00 | 0.2442 |
54209 | TREM2 | SYSMH6 | Human | Oral cavity | OSCC | 1.66e-02 | 4.92e-01 | 0.1275 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0010498111 | Esophagus | ESCC | proteasomal protein catabolic process | 369/8552 | 490/18723 | 1.13e-41 | 1.80e-38 | 369 |
GO:0097193111 | Esophagus | ESCC | intrinsic apoptotic signaling pathway | 222/8552 | 288/18723 | 5.87e-28 | 2.02e-25 | 222 |
GO:0042176111 | Esophagus | ESCC | regulation of protein catabolic process | 280/8552 | 391/18723 | 8.65e-26 | 2.39e-23 | 280 |
GO:2001233111 | Esophagus | ESCC | regulation of apoptotic signaling pathway | 256/8552 | 356/18723 | 4.11e-24 | 1.04e-21 | 256 |
GO:0022411111 | Esophagus | ESCC | cellular component disassembly | 305/8552 | 443/18723 | 1.94e-23 | 4.57e-21 | 305 |
GO:0009896111 | Esophagus | ESCC | positive regulation of catabolic process | 332/8552 | 492/18723 | 4.36e-23 | 9.22e-21 | 332 |
GO:0006979111 | Esophagus | ESCC | response to oxidative stress | 303/8552 | 446/18723 | 7.15e-22 | 1.30e-19 | 303 |
GO:0031331111 | Esophagus | ESCC | positive regulation of cellular catabolic process | 292/8552 | 427/18723 | 8.67e-22 | 1.53e-19 | 292 |
GO:1903362111 | Esophagus | ESCC | regulation of cellular protein catabolic process | 188/8552 | 255/18723 | 5.12e-20 | 6.62e-18 | 188 |
GO:0045862111 | Esophagus | ESCC | positive regulation of proteolysis | 256/8552 | 372/18723 | 7.88e-20 | 9.43e-18 | 256 |
GO:1903829111 | Esophagus | ESCC | positive regulation of cellular protein localization | 199/8552 | 276/18723 | 2.99e-19 | 3.45e-17 | 199 |
GO:0062197111 | Esophagus | ESCC | cellular response to chemical stress | 234/8552 | 337/18723 | 5.37e-19 | 5.97e-17 | 234 |
GO:001050617 | Esophagus | ESCC | regulation of autophagy | 220/8552 | 317/18723 | 6.72e-18 | 6.36e-16 | 220 |
GO:1903050111 | Esophagus | ESCC | regulation of proteolysis involved in cellular protein catabolic process | 163/8552 | 221/18723 | 1.44e-17 | 1.27e-15 | 163 |
GO:2001242111 | Esophagus | ESCC | regulation of intrinsic apoptotic signaling pathway | 128/8552 | 164/18723 | 1.75e-17 | 1.50e-15 | 128 |
GO:0061136111 | Esophagus | ESCC | regulation of proteasomal protein catabolic process | 142/8552 | 187/18723 | 2.40e-17 | 2.00e-15 | 142 |
GO:0045732111 | Esophagus | ESCC | positive regulation of protein catabolic process | 167/8552 | 231/18723 | 1.47e-16 | 1.14e-14 | 167 |
GO:0043254111 | Esophagus | ESCC | regulation of protein-containing complex assembly | 278/8552 | 428/18723 | 3.81e-16 | 2.77e-14 | 278 |
GO:1904951111 | Esophagus | ESCC | positive regulation of establishment of protein localization | 216/8552 | 319/18723 | 1.01e-15 | 6.86e-14 | 216 |
GO:0034599111 | Esophagus | ESCC | cellular response to oxidative stress | 197/8552 | 288/18723 | 3.76e-15 | 2.15e-13 | 197 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa043806 | Oral cavity | OSCC | Osteoclast differentiation | 73/3704 | 128/8465 | 1.60e-03 | 4.44e-03 | 2.26e-03 | 73 |
hsa0438011 | Oral cavity | OSCC | Osteoclast differentiation | 73/3704 | 128/8465 | 1.60e-03 | 4.44e-03 | 2.26e-03 | 73 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TREM2 | SNV | Missense_Mutation | c.538G>A | p.Ala180Thr | p.A180T | Q9NZC2 | protein_coding | deleterious(0.04) | possibly_damaging(0.638) | TCGA-BG-A0M3-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TREM2 | SNV | Missense_Mutation | c.59N>G | p.Asn20Ser | p.N20S | Q9NZC2 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-BS-A0TJ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
TREM2 | SNV | Missense_Mutation | c.144N>T | p.Lys48Asn | p.K48N | Q9NZC2 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-BS-A0UF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TREM2 | SNV | Missense_Mutation | novel | c.251N>G | p.Ile84Ser | p.I84S | Q9NZC2 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-DF-A2KN-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
TREM2 | SNV | Missense_Mutation | novel | c.175N>T | p.Pro59Ser | p.P59S | Q9NZC2 | protein_coding | tolerated(0.65) | benign(0.237) | TCGA-EO-A22U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TREM2 | SNV | Missense_Mutation | novel | c.365N>T | p.Arg122Met | p.R122M | Q9NZC2 | protein_coding | deleterious(0.02) | possibly_damaging(0.69) | TCGA-EO-A3B0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
TREM2 | SNV | Missense_Mutation | c.538G>C | p.Ala180Pro | p.A180P | Q9NZC2 | protein_coding | deleterious(0) | possibly_damaging(0.881) | TCGA-44-8117-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
TREM2 | SNV | Missense_Mutation | c.454N>T | p.Asp152Tyr | p.D152Y | Q9NZC2 | protein_coding | deleterious(0.03) | possibly_damaging(0.459) | TCGA-50-5933-01 | Lung | lung adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | carboplatin | CR | |
TREM2 | SNV | Missense_Mutation | novel | c.680N>G | p.Leu227Arg | p.L227R | Q9NZC2 | protein_coding | tolerated_low_confidence(0.78) | benign(0.001) | TCGA-55-7574-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | PD |
TREM2 | SNV | Missense_Mutation | c.619N>A | p.Pro207Thr | p.P207T | Q9NZC2 | protein_coding | tolerated(0.51) | benign(0.04) | TCGA-55-8092-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |